{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:18:53Z","timestamp":1780575533128,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Laboratory of Advanced Biotechnology Project","award":["BDZZ202204"],"award-info":[{"award-number":["BDZZ202204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00253-023-12796-7","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:01:32Z","timestamp":1695484892000},"page":"7197-7211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tetanus toxin and botulinum neurotoxin\u2013derived fusion molecules are effective bivalent vaccines"],"prefix":"10.1007","volume":"107","author":[{"given":"Bo-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-9688","authenticated-orcid":false,"given":"Yun-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"issue":"8","key":"12796_CR1","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1080\/21505594.2017.1321726","volume":"8","author":"H Alsarraf","year":"2017","unstructured":"Alsarraf H, Dedic E, Bjerrum MJ, \u00d8stergaard O, Kristensen MP, Petersen JW, J\u00f8rgensen R (2017) Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines. Virulence 8(8):1880\u20131889. https:\/\/doi.org\/10.1080\/21505594.2017.1321726","journal-title":"Virulence"},{"key":"12796_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-319-72077-7_9","volume":"1053","author":"A Avril","year":"2017","unstructured":"Avril A (2017) Therapeutic antibodies for biodefense. Adv Exp Med Biol 1053:173\u2013205. https:\/\/doi.org\/10.1007\/978-3-319-72077-7_9","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"12796_CR3","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1128\/iai.01025-07","volume":"76","author":"MR Baldwin","year":"2008","unstructured":"Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT (2008) Subunit vaccine against the seven serotypes of botulism. Infect Immun 76(3):1314\u20131318. https:\/\/doi.org\/10.1128\/iai.01025-07","journal-title":"Infect Immun"},{"key":"12796_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jchromb.2017.04.009","volume":"1054","author":"C Bayart","year":"2017","unstructured":"Bayart C, Peronin S, Jean E, Paladino J, Talaga P, Borgne ML (2017) The combined use of analytical tools for exploring tetanus toxin and tetanus toxoid structures. J Chromatogr B Analyt Technol Biomed Life Sci 1054:80\u201392. https:\/\/doi.org\/10.1016\/j.jchromb.2017.04.009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"12796_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00253-021-11139-8","volume":"105","author":"P Chai","year":"2021","unstructured":"Chai P, Pu X, Ge J, Ren S, Xia X, Luo A, Wang S, Wang X, Li J (2021) The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197. Appl Microbiol Biotechnol 105(4):1683\u20131692. https:\/\/doi.org\/10.1007\/s00253-021-11139-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"12796_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/82_2017_50","volume":"406","author":"C Connan","year":"2017","unstructured":"Connan C, Popoff MR (2017) Uptake of clostridial neurotoxins into cells and dissemination. Curr Top Microbiol Immunol 406:39\u201378. https:\/\/doi.org\/10.1007\/82_2017_50","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5773","key":"12796_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312(5773):592\u2013596. https:\/\/doi.org\/10.1126\/science.1123654","journal-title":"Science"},{"key":"12796_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1146\/annurev-biochem-013118-111654","volume":"88","author":"M Dong","year":"2019","unstructured":"Dong M, Masuyer G, Stenmark P (2019) Botulinum and tetanus neurotoxins. Annu Rev Biochem 88:811\u2013837. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111654","journal-title":"Annu Rev Biochem"},{"issue":"34","key":"12796_CR9","doi-asserted-by":"publisher","first-page":"32274","DOI":"10.1074\/jbc.M103285200","volume":"276","author":"C Fotinou","year":"2001","unstructured":"Fotinou C, Emsley P, Black I, Ando H, Ishida H, Kiso M, Sinha KA, Fairweather NF, Isaacs NW (2001) The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J Biol Chem 276(34):32274\u201332281. https:\/\/doi.org\/10.1074\/jbc.M103285200","journal-title":"J Biol Chem"},{"issue":"2","key":"12796_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12640-019-00096-w","volume":"37","author":"S Ghotloo","year":"2020","unstructured":"Ghotloo S, Golsaz-Shirazi F, Amiri MM, Jeddi-Tehrani M, Shokri F (2020) Epitope mapping of tetanus toxin by monoclonal antibodies: implication for immunotherapy and vaccine design. Neurotox Res 37(2):239\u2013249. https:\/\/doi.org\/10.1007\/s12640-019-00096-w","journal-title":"Neurotox Res"},{"issue":"41","key":"12796_CR11","doi-asserted-by":"publisher","first-page":"35966","DOI":"10.1074\/jbc.M111.283879","volume":"286","author":"CB Harper","year":"2011","unstructured":"Harper CB, Martin S, Nguyen TH, Daniels SJ, Lavidis NA, Popoff MR, Hadzic G, Mariana A, Chau N, McCluskey A, Robinson PJ, Meunier FA (2011) Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem 286(41):35966\u201335976. https:\/\/doi.org\/10.1074\/jbc.M111.283879","journal-title":"J Biol Chem"},{"issue":"3","key":"12796_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.mib.2012.05.009","volume":"15","author":"AP Karalewitz","year":"2012","unstructured":"Karalewitz AP, Barbieri JT (2012) Vaccines against botulism. Curr Opin Microbiol 15(3):317\u2013324. https:\/\/doi.org\/10.1016\/j.mib.2012.05.009","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"12796_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1128\/cvi.00117-08","volume":"15","author":"JE Keller","year":"2008","unstructured":"Keller JE (2008) Characterization of new formalin-detoxified botulinum neurotoxin toxoids. Clin Vaccine Immunol 15(9):1374\u20131379. https:\/\/doi.org\/10.1128\/cvi.00117-08","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"12796_CR14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s12640-021-00337-x","volume":"39","author":"Z Li","year":"2021","unstructured":"Li Z, Lu JS, Liu S, Wang R, Xu Q, Yu YZ, Yang ZX (2021) Recombinant L-HN fusion antigen derived from the L and HN domains of botulinum neurotoxin B stimulates a protective antibody response against active neurotoxin. Neurotox Res 39(4):1044\u20131053. https:\/\/doi.org\/10.1007\/s12640-021-00337-x","journal-title":"Neurotox Res"},{"key":"12796_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.toxicon.2020.08.001","volume":"187","author":"FJ Liu","year":"2020","unstructured":"Liu FJ, Shi DY, Li ZY, Lu JS, Wang R, Pang XB, Yang ZX, Yu YZ (2020a) Evaluation of a recombinant tetanus toxin subunit vaccine. Toxicon 187:75\u201381. https:\/\/doi.org\/10.1016\/j.toxicon.2020.08.001","journal-title":"Toxicon"},{"issue":"14","key":"12796_CR16","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1016\/j.vaccine.2020.02.060","volume":"38","author":"FJ Liu","year":"2020","unstructured":"Liu FJ, Shi DY, Mao YY, Xiong XH, Lu JS, Pang XB, Dong XJ, Yang ZX, Yu YZ (2020b) Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A. Vaccine 38(14):2978\u20132983. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.060","journal-title":"Vaccine"},{"issue":"8","key":"12796_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/toxins12080509","volume":"12","author":"D Lonati","year":"2020","unstructured":"Lonati D, Schicchi A, Crevani M, Buscaglia E, Scaravaggi G, Maida F, Cirronis M, Petrolini VM, Locatelli CA (2020) Foodborne botulism: clinical diagnosis and medical treatment. Toxins (Basel) 12(8):509. https:\/\/doi.org\/10.3390\/toxins12080509","journal-title":"Toxins (Basel)"},{"issue":"3","key":"12796_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/infdis\/jiv327","volume":"213","author":"SE Maslanka","year":"2016","unstructured":"Maslanka SE, L\u00faquez C, Dykes JK, Tepp WH, Pier CL, Pellett S, Raphael BH, Kalb SR, Barr JR, Rao A, Johnson EA (2016) A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J Infect Dis 213(3):379\u2013385. https:\/\/doi.org\/10.1093\/infdis\/jiv327","journal-title":"J Infect Dis"},{"issue":"1","key":"12796_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.xphs.2019.10.047","volume":"109","author":"B Metz","year":"2020","unstructured":"Metz B, Michiels T, Uittenbogaard J, Danial M, Tilstra W, Meiring HD, Hennink WE, Crommelin DJA, Kersten GFA, Jiskoot W (2020) Identification of formaldehyde-induced modifications in diphtheria toxin. J Pharm Sci 109(1):543\u2013557. https:\/\/doi.org\/10.1016\/j.xphs.2019.10.047","journal-title":"J Pharm Sci"},{"issue":"9","key":"12796_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.addr.2005.01.016","volume":"57","author":"JL Middlebrook","year":"2005","unstructured":"Middlebrook JL (2005) Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv Drug Deliv Rev 57(9):1415\u20131423. https:\/\/doi.org\/10.1016\/j.addr.2005.01.016","journal-title":"Adv Drug Deliv Rev"},{"key":"12796_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","volume":"11","author":"C Montecucco","year":"1986","unstructured":"Montecucco C (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11:314\u2013317","journal-title":"Trends Biochem Sci"},{"key":"12796_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.anaerobe.2014.06.003","volume":"28","author":"GM Moreira","year":"2014","unstructured":"Moreira GM, Cunha CE, Salvarani FM, Gon\u00e7alves LA, Pires PS, Concei\u00e7\u00e3o FR, Lobato FC (2014) Production of recombinant botulism antigens: a review of expression systems. Anaerobe 28:130\u2013136. https:\/\/doi.org\/10.1016\/j.anaerobe.2014.06.003","journal-title":"Anaerobe"},{"issue":"suppl_1","key":"12796_CR23","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/cid\/cix815","volume":"66","author":"JC O'Horo","year":"2017","unstructured":"O\u2019Horo JC, Harper EP, El Rafei A, Ali R, DeSimone DC, Sakusic A, Abu Saleh OM, Marcelin JR, Tan EM, Rao AK, Sobel J, Tosh PK (2017) Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923\u20132016. Clin Infect Dis 66(suppl_1):S43-s56. https:\/\/doi.org\/10.1093\/cid\/cix815","journal-title":"Clin Infect Dis"},{"issue":"2","key":"12796_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69(2):200\u2013235. https:\/\/doi.org\/10.1124\/pr.116.012658","journal-title":"Pharmacol Rev"},{"key":"12796_CR25","doi-asserted-by":"publisher","unstructured":"Poulain B, Popoff MR (2019) Why are botulinum neurotoxin-producing bacteria so diverse and botulinum neurotoxins so toxic? Toxins (Basel) 11(1) https:\/\/doi.org\/10.3390\/toxins11010034","DOI":"10.3390\/toxins11010034"},{"issue":"3","key":"12796_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/ije\/31.3.648","volume":"31","author":"A Quddus","year":"2002","unstructured":"Quddus A, Luby S, Rahbar M, Pervaiz Y (2002) Neonatal tetanus: mortality rate and risk factors in Loralai District. Pakistan Int J Epidemiol 31(3):648\u2013653. https:\/\/doi.org\/10.1093\/ije\/31.3.648","journal-title":"Pakistan Int J Epidemiol"},{"issue":"12","key":"12796_CR27","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s12098-011-0666-8","volume":"79","author":"R Rai","year":"2012","unstructured":"Rai R, Singh DK (2012) Neonatal tetanus: a continuing challenge. Indian J Pediatr 79(12):1648\u20131650. https:\/\/doi.org\/10.1007\/s12098-011-0666-8","journal-title":"Indian J Pediatr"},{"issue":"6","key":"12796_CR28","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1128\/iai.01893-06","volume":"75","author":"E Ravichandran","year":"2007","unstructured":"Ravichandran E, Al-Saleem FH, Ancharski DM, Elias MD, Singh AK, Shamim M, Gong Y, Simpson LL (2007) Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun 75(6):3043\u20133054. https:\/\/doi.org\/10.1128\/iai.01893-06","journal-title":"Infect Immun"},{"issue":"3","key":"12796_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11095-015-1816-x","volume":"33","author":"E Ravichandran","year":"2016","unstructured":"Ravichandran E, Janardhanan P, Patel K, Riding S, Cai S, Singh BR (2016) In vivo toxicity and immunological characterization of detoxified recombinant botulinum neurotoxin type A. Pharm Res 33(3):639\u2013652. https:\/\/doi.org\/10.1007\/s11095-015-1816-x","journal-title":"Pharm Res"},{"issue":"12","key":"12796_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/toxins11120686","volume":"11","author":"O Rossetto","year":"2019","unstructured":"Rossetto O, Montecucco C (2019) Tables of toxicity of botulinum and tetanus neurotoxins. Toxins 11(12):686. https:\/\/doi.org\/10.3390\/toxins11120686","journal-title":"Toxins"},{"key":"12796_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-642-33570-9_4","volume":"364","author":"A Rummel","year":"2013","unstructured":"Rummel A (2013) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364:61\u201390. https:\/\/doi.org\/10.1007\/978-3-642-33570-9_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"12796_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2016_48","volume":"406","author":"A Rummel","year":"2017","unstructured":"Rummel A (2017) Two feet on the membrane: uptake of clostridial neurotoxins. Curr Top Microbiol Immunol 406:1\u201337. https:\/\/doi.org\/10.1007\/82_2016_48","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"12796_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pep.2005.07.020","volume":"45","author":"S Sharma","year":"2006","unstructured":"Sharma S, Zhou Y, Singh BR (2006) Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A. Protein Expr Purif 45(2):288\u2013295. https:\/\/doi.org\/10.1016\/j.pep.2005.07.020","journal-title":"Protein Expr Purif"},{"issue":"45","key":"12796_CR34","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1016\/j.vaccine.2010.08.076","volume":"28","author":"JD Shearer","year":"2010","unstructured":"Shearer JD, Vassar ML, Swiderski W, Metcalfe K, Niemuth N, Henderson I (2010) Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A\/B). Vaccine 28(45):7313\u20137318. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.076","journal-title":"Vaccine"},{"issue":"11","key":"12796_CR35","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.vaccine.2012.01.035","volume":"30","author":"JD Shearer","year":"2012","unstructured":"Shearer JD, Manetz TS, House RV (2012) Preclinical safety assessment of recombinant botulinum vaccine A\/B (rBV A\/B). Vaccine 30(11):1917\u20131926. https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.035","journal-title":"Vaccine"},{"issue":"3","key":"12796_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/21645515.2018.1547613","volume":"15","author":"DY Shi","year":"2019","unstructured":"Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW (2019) Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B. Hum Vaccin Immunother 15(3):755\u2013760. https:\/\/doi.org\/10.1080\/21645515.2018.1547613","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"12796_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/21645515.2019.1633878","volume":"16","author":"DY Shi","year":"2020","unstructured":"Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB (2020) Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E. Hum Vaccin Immunother 16(1):100\u2013108. https:\/\/doi.org\/10.1080\/21645515.2019.1633878","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"12796_CR38","doi-asserted-by":"publisher","first-page":"2048621","DOI":"10.1080\/21645515.2022.2048621","volume":"18","author":"DY Shi","year":"2022","unstructured":"Shi DY, Liu FJ, Li ZY, Mao YY, Lu JS, Wang R, Pang XB, Yu YZ, Yang ZX (2022) Development and evaluation of a tetravalent botulinum vaccine. Hum Vaccin Immunother 18(5):2048621. https:\/\/doi.org\/10.1080\/21645515.2022.2048621","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"12796_CR39","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00253-023-12515-2","volume":"107","author":"DY Shi","year":"2023","unstructured":"Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX (2023) Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs. Appl Microbiol Biotechnol 107(10):3205\u20133216. https:\/\/doi.org\/10.1007\/s00253-023-12515-2","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"12796_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/toxins9090268","volume":"9","author":"G Sundeen","year":"2017","unstructured":"Sundeen G, Barbieri JT (2017) Vaccines against botulism. Toxins (Basel) 9(9):268. https:\/\/doi.org\/10.3390\/toxins9090268","journal-title":"Toxins (Basel)"},{"issue":"5","key":"12796_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/toxins10050190","volume":"10","author":"D Tehran","year":"2018","unstructured":"Tehran D, Pirazzini M (2018) Novel botulinum neurotoxins: exploring underneath the iceberg tip. Toxins 10(5):190. https:\/\/doi.org\/10.3390\/toxins10050190","journal-title":"Toxins"},{"issue":"9965","key":"12796_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/s0140-6736(14)60236-1","volume":"385","author":"CL Thwaites","year":"2015","unstructured":"Thwaites CL, Beeching NJ, Newton CR (2015) Maternal and neonatal tetanus. Lancet 385(9965):362\u2013370. https:\/\/doi.org\/10.1016\/s0140-6736(14)60236-1","journal-title":"Lancet"},{"issue":"9","key":"12796_CR43","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/jps.20880","volume":"96","author":"C Vessely","year":"2007","unstructured":"Vessely C, Estey T, Randolph TW, Henderson I, Nayar R, Carpenter JF (2007) Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants. J Pharm Sci 96(9):2375\u20132389. https:\/\/doi.org\/10.1002\/jps.20880","journal-title":"J Pharm Sci"},{"issue":"9","key":"12796_CR44","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/jps.21498","volume":"98","author":"C Vessely","year":"2009","unstructured":"Vessely C, Estey T, Randolph TW, Henderson I, Cooper J, Nayar R, Braun LJ, Carpenter JF (2009) Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution. J Pharm Sci 98(9):2970\u20132993. https:\/\/doi.org\/10.1002\/jps.21498","journal-title":"J Pharm Sci"},{"issue":"5","key":"12796_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/erv.13.37","volume":"12","author":"RP Webb","year":"2013","unstructured":"Webb RP, Smith LA (2013) What next for botulism vaccine development? Expert Rev Vaccines 12(5):481\u2013492. https:\/\/doi.org\/10.1586\/erv.13.37","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"12796_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/toxins9030093","volume":"9","author":"G Yao","year":"2017","unstructured":"Yao G, Lam K-h, Perry K, Weisemann J, Rummel A, Jin R (2017) Crystal structure of the receptor-binding domain of botulinum neurotoxin type HA, also known as type FA or H. Toxins 9(3):93. https:\/\/doi.org\/10.3390\/toxins9030093","journal-title":"Toxins"},{"issue":"11","key":"12796_CR47","doi-asserted-by":"publisher","first-page":"e1001207","DOI":"10.1371\/journal.ppat.1001207","volume":"6","author":"FL Yeh","year":"2010","unstructured":"Yeh FL, Dong M, Yao J, Tepp WH, Lin G, Johnson EA, Chapman ER (2010) SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog 6(11):e1001207. https:\/\/doi.org\/10.1371\/journal.ppat.1001207","journal-title":"PLoS Pathog"},{"issue":"12","key":"12796_CR48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1128\/cvi.00239-08","volume":"15","author":"YZ Yu","year":"2008","unstructured":"Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW (2008) Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine. Clin Vaccine Immunol 15(12):1819\u20131823. https:\/\/doi.org\/10.1128\/cvi.00239-08","journal-title":"Clin Vaccine Immunol"},{"issue":"21","key":"12796_CR49","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","volume":"27","author":"YZ Yu","year":"2009","unstructured":"Yu YZ, Li N, Zhu HQ, Wang RL, Du Y, Wang S, Yu WY, Sun ZW (2009) The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate. Vaccine 27(21):2816\u20132822. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.091","journal-title":"Vaccine"},{"issue":"10","key":"12796_CR50","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4161\/hv.7.10.16763","volume":"7","author":"YZ Yu","year":"2011","unstructured":"Yu YZ, Ma Y, Chen YX, Gong ZW, Wang S, Yu WY, Sun ZW (2011) Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A. Hum Vaccin 7(10):1090\u20131095. https:\/\/doi.org\/10.4161\/hv.7.10.16763","journal-title":"Hum Vaccin"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12796-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-023-12796-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12796-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T06:03:45Z","timestamp":1699596225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-023-12796-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":50,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["12796"],"URL":"https:\/\/doi.org\/10.1007\/s00253-023-12796-7","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institution of Animal Care and Use Committee of the Beijing Institute of Biotechnology and performed with the permission of the Institute of Animal Care and Use Committee (IACUC) at the Academy of Military Medical Science, with the ethical approval number IACUC-DWZX-2021\u2013014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}